INTERNATIONAL SOCIETY FOR      DISEASES OF THE ESOPHAGUS

  • Home
  • News & Events
  • Literature Updates
  • Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer

Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer

02 Feb 2017 2:18 AM | Anonymous

Shapiro, Joel MD; Biermann, Katharina MD, PhD; van Klaveren, David MSc; Offerhaus, G. Johan A. MD, PhD; ten Kate, Fiebo J. W. MD, PhD; Meijer, Sybren L. MD, PhD; van Berge Henegouwen, Mark I. MD, PhD; Steyerberg, Ewout W. MD, PhD; Wijnhoven, Bas P. L. MD, PhD; Lanschot, J. Jan B. van MD, PhD

Click HERE for more information


© International Society for Diseases of the Esophagus 2016

Powered by Wild Apricot Membership Software